Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer.

Italo Fernandes, Anderson Scorsato,Rafael Kaliks,Marcus Corpa,Eduarda Damasceno,Gustavo Schvartsman

Clinical breast cancer（2023）

引用 0|浏览2

暂无评分

摘要

TILs in HER2-low are marginally higher than HER2-negative, but significantly lower than HER2-positive levels. HER2-low tumors do not seem to significantly differ biologically from HER2-negative tumors.

查看译文

关键词

Biomarkers, Tumor Infiltrating Lymphocytes, HER2 Breast Cancer Spectrum

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要